Question

Please help

Below is lab test

Test.   Result.   Reference Range

RBC 3.21.   4.40-5.60

HGB.   9.7.   13.0-18.0

HCT.   30.1. 38.0-50.0

RDW-SD. 46.7.   36.5-45.9

MPV.   11.2.   7.4-10.4

GLUCOSE   263.   70-105

UREA NITROGEN   25.   6-20

SODIUM.   132.   133-145

chloride 94. 96-108

Base on lab test please answer these question below for each result

Lab Tests and Diagnostic Exams performed on patient (Include both normal and abnormal results): QSEN skill: Use information management tools to monitor outcomes of care processes.

Why is this information needed? Explain a high or low result and explain how the results relate to your patient. Include pathology, diet and medications in this explanation. Add more rows if needed.

Answer 1

Lab Result

RBC	3.21
HGB	9.7
HCT	30.1
RDW	46.7
MPV	11.2
Glucose	263
Urea Nitrogen	25
Sodium	132
Chloride	94

Red cell distribution width (RDW) was significantly higher in diabetic patients. RDW, which is recently considered as an inflammatory marker and is significantly higher in diabetic patients than healthy subjects and is particularly higher in uncontrolled glycemia. Elevated RDW is independently related to future HbA1c elevation, but not to glucose elevation. This suggests that RDW may associate with HbA1c through a non-glycemic way, which should be taken into consideration when using HbA1c as a diagnostic criterion of prediabetes or diabetes. It’s common for people with diabetes to also end up with this anaemia. Diabetes often leads to kidney damage, and failing kidneys can cause anaemia.

Diet:

Diet may include good sources of iron include:

• Iron-fortified bread and cereals
• Beans and lentils
• Oysters
• Liver
• Green leafy vegetables, especially spinach
• Tofu
• Red meat
• Fish
• Dried fruit, like prunes, raisins and apricots

Treatments include diet, exercise, medication and insulin therapy

Medications:

Sulfonylurea

-There are two generations of sulfonylureas; 1st generation is less potent than a 2nd generation (which are 1000x more potent). 2nd generation SU is preferred, due to their increased effectiveness and decreased side effects.

-Insulin-sensitizing agents-Thiazolidinediones (TZD)

Another strategy for the treatment of T2D is not only to optimize glucose control but also to
treat insulin resistance.

-Incretins:Glucagon-like peptide-1 (GLP-1) analogues

-Insulin therapy